Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02262364 · ClinicalTrials.gov registry record · Phase 1
Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)
A Phase 1 study, sponsored by Zimmer Biomet.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT02262364 is a Phase 1 study that has completed, run by Zimmer Biomet. The registered enrollment target is 11 participants.
The verdict
NCT02262364, a Phase 1 study, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the safety of a single injection of APS.
Interventions
- BIOLOGICAL APS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02262364
The ClinicalTrials.gov registry entry for NCT02262364 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which APS is the first listed.
NCT02262364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02262364 about?
NCT02262364 is a clinical study titled "Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)". The primary objective of this study is to assess the safety of a single injection of APS.
What is the current status of trial NCT02262364?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2014-11. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02262364?
The interventions under investigation include: APS (BIOLOGICAL).
Who is sponsoring clinical trial NCT02262364?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.